covid heroes

Houston university announces first recipients of coronavirus research funding

Four COVID-19-focused research projects have been selected by Rice University to receive funding. Photo courtesy of Rice University

Rice University has named several Houston researchers as recipients of funding as a part of a new initiative to support projects that are innovating solutions and services amid the COVID-19 crisis.

The university's COVID-19 Research Fund Oversight and Review Committee — led by engineering professor and special adviser to the provost, Marcia O'Malley — selected a few projects led by Rice faculty members across industries from biomedicine to humanities that will receive the first round of funds. However, the application window is ongoing, according to a press release, and additional awards are to be expected.

Here were the first projects and researchers to be selected by the committee.

A low-cost diagnostic tool

Rice researchers Rebecca Richards-Kortum and Kathryn Kundrod of Rice University along with Kathleen Schmeler of the University of Texas MD Anderson Cancer Center have identified a way to create a COVID-19 diagnostic device that costs less than $5,000 and less than $2 per test. It would also take fewer than 30 minutes to diagnose.

The researchers are also working with USAID and industry partners on a plan to scale the test to five countries in Africa. In the future, the device would enable broader SARS-CoV-2 testing locally and in low- and middle-income countries.

Richards-Kortum is a professor of bioengineering and electrical and computer engineering and director of Rice 360˚. Kundrod is a graduate student in bioengineering. Schmeler is a professor in the department of gynecologic oncology and reproductive medicine at MD Anderson.

A protective rubber harness to be worn over a face mask 

Jacob Robinson and Caleb Kemere, associate professors at Rice, along with Sahil Kuldip of MD Anderson, have discovered a low-cost, easy-to-manufacture rubber harness to be worn over surgical or cloth masks in order seal the masks. The seal would better prevent small airborne particles from getting around the masks.

Robinson is in Rice's electrical and computer engineering and bioengineering departments, while Kemere specializes in electrical and computer engineering. Kuldip is an assistant professor of plastic surgery at MD Anderson.

Wastewater monitoring for coronavirus contamination 

Rice researchers Lauren Stadler, Katherine Ensor and Loren Hopkins are working with the Houston Health Department and Houston Water on a plan to collect wastewater samples from local treatment plants to monitor for the presence of COVID-19.

With most people asymptomatic or experience only mild symptoms of COVID-19, the researchers are looking into the virus's presence in wastewater in order to track community infection.

Stadler, an assistant professor of civil and environmental engineering, and Ensor, the Noah G. Harding Professor of Statistics, are working with Hopkins, who is a professor in practice of statistics and chief environmental science officer for the Houston Health Department.

The identification of safe and healthy voting procedures 

Five Rice researchers — Robert Stein, Philip Kortum, Claudia Ziegler Acemyan, Daniel Wallach and Elizabeth Vann — are looking into steps Harris County can take to ensure that in-person voting is safe and keeps participants healthy. Through surveys with citizens, the team will help election officials survey both voters and poll workers on their voting preferences and concerns.

The research team spans campus departments: Stein is the Lena Gohlman Fox Professor of Political Science, Kortum is an associate professor of psychological sciences, Acemyan is an adjunct assistant professor of psychological sciences, Wallach is a professor of computer science and of electrical and computer engineering, and Vann is the director of programs and partnerships at the Center for Civic Leadership

Trending News

 
 

Promoted

A research team housed out of the newly launched Rice Biotech Launch Pad received funding to scale tech that could slash cancer deaths in half. Photo via Rice University

A research funding agency has deployed capital into a team at Rice University that's working to develop a technology that could cut cancer-related deaths in half.

Rice researchers received $45 million from the National Institutes of Health's Advanced Research Projects Agency for Health, or ARPA-H, to scale up development of a sense-and-respond implant technology. Rice bioengineer Omid Veiseh leads the team developing the technology as principal investigator.

“Instead of tethering patients to hospital beds, IV bags and external monitors, we’ll use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time,” he says in a news release. “This kind of ‘closed-loop therapy’ has been used for managing diabetes, where you have a glucose monitor that continuously talks to an insulin pump. But for cancer immunotherapy, it’s revolutionary.”

Joining Veiseh on the 19-person research project named THOR, which stands for “targeted hybrid oncotherapeutic regulation,” is Amir Jazaeri, co-PI and professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center. The device they are developing is called HAMMR, or hybrid advanced molecular manufacturing regulator.

“Cancer cells are continually evolving and adapting to therapy. However, currently available diagnostic tools, including radiologic tests, blood assays and biopsies, provide very infrequent and limited snapshots of this dynamic process," Jazaeri adds. "As a result, today’s therapies treat cancer as if it were a static disease. We believe THOR could transform the status quo by providing real-time data from the tumor environment that can in turn guide more effective and tumor-informed novel therapies.”

With a national team of engineers, physicians, and experts across synthetic biology, materials science, immunology, oncology, and more, the team will receive its funding through the Rice Biotech Launch Pad, a newly launched initiative led by Veiseh that exists to help life-saving medical innovation scale quickly.

"Rice is proud to be the recipient of the second major funding award from the ARPA-H, a new funding agency established last year to support research that catalyzes health breakthroughs," Rice President Reginald DesRoches says. "The research Rice bioengineer Omid Veiseh is doing in leading this team is truly groundbreaking and could potentially save hundreds of thousands of lives each year. This is the type of research that makes a significant impact on the world.”

The initial focus of the technology will be on ovarian cancer, and this funding agreement includes a first-phase clinical trial of HAMMR for the treatment of recurrent ovarian cancer that's expected to take place in the fourth year of THOR’s multi-year project.

“The technology is broadly applicable for peritoneal cancers that affect the pancreas, liver, lungs and other organs,” Veiseh says. “The first clinical trial will focus on refractory recurrent ovarian cancer, and the benefit of that is that we have an ongoing trial for ovarian cancer with our encapsulated cytokine ‘drug factory’ technology. We'll be able to build on that experience. We have already demonstrated a unique model to go from concept to clinical trial within five years, and HAMMR is the next iteration of that approach.”

Trending News

 
 

Promoted